INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 08/30/23
Novocure Announces The Lancet Oncology Publishes Primary Data from Phase 3 LUNAR Clinical Trial in Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based TherapiesBusiness Wire • 08/29/23
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 08/29/23
Novocure stock plummets after Phase 3 cancer trial fails to reach desired endpointProactive Investors • 08/28/23
Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian CancerInvestors Business Daily • 08/28/23
Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial Evaluating Tumor Treating Fields Therapy in Platinum-resistant Ovarian CancerBusiness Wire • 08/28/23
NVCR LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving NovoCure LimitedAccesswire • 08/18/23
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 08/18/23
NVCR Investors Have Opportunity to Lead NovoCure Limited Securities Fraud LawsuitPRNewsWire • 08/17/23
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)Business Wire • 08/17/23
NVCR LAWSUIT ALERT: Levi & Korsinsky Notifies NovoCure Limited Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 08/17/23
FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 08/17/23
NVCR IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCRPRNewsWire • 08/16/23
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NovoCure Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 18, 2023 - (NASDAQ: NVCR)PRNewsWire • 08/16/23